Skip to main content
Insights into Imaging
Fig. 24 | Insights into Imaging

Fig. 24

From: Assessment of hepatocellular carcinoma treatment response with LI-RADS: a pictorial review

Fig. 24

Axial T1-weighted MR in late arterial phase obtained (a) pretreatment: image shows two LR-4 observations (arrows) with nonrim arterial phase hyperenhancement (APHE). b 2 months post drug-eluting beads TACE (DEB-TACE): image shows regional APHE (asterisk). c 10 months post DEB-TACE: image shows decrease in regional APHE (asterisk). No nodular enhancement nor washout is visible. The treated observation is categorized LR-TR nonviable. Note the radiofrequency ablation cavity of another treated lesion (arrowhead)

Back to article page